IL6 and gastric adenocarcinoma: No mutations have been detected in key positions of glycoprotein 130 (gp130) in human gastric adenocarcinoma samples; however, gp130 activation may occur due to increased expression levels of the IL-6 and IL-11 cytokines, which have potential as valuable biomarkers (54).